Your browser doesn't support javascript.
loading
Adenosine 3':5'-monophosphate-regulated phosphorylation of erythrocyte membrane proteins. Separation of membrane-associated cyclic adenosine 3':5'-monophosphate-dependent protein kinase from its endogenous substrates.
J Biol Chem ; 250(23): 9044-52, 1975 Dec 10.
Article em En | MEDLINE | ID: mdl-172503
ABSTRACT
An adenosine 3'5'-monophosphate (cyclic AMP)-binding protein in the human erythrocyte plasma membrane was isotopically labeled using a photoaffinity analog of cyclic AMP, N6-(ethyl 2-diazomalonyl) cyclic [3H]AMP. The cyclic AMP-binding site is located in a polypeptide chain having a molecular weight of 48,000. Cyclic AMP-binding protein and cyclic AMP-dependent protein kinase were solubilized with 0.5% Triton X-100 in 56 mM sodium borate, pH 8, but 32P-labeled membrane phosphoproteins were retained in the Triton-insoluble fraction, suggesting that the membrane-associated binding protein is not a primary substrate for protein kinase. Triton-solubilized and membrane-associated protein kinase activities were stimulated 15- and 17-fold by cyclic AMP, suggesting that the degree of association between the catalytic anc cyclic AMP-binding components was very similar in both preparations. Fractionation and characterization of membrane phosphoproteins have shown that protein III and a co-migrating minor protein are substrates for protein kinase but membrane sialoglycoproteins are not phosphorylated.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Proteínas Quinases / AMP Cíclico / Eritrócitos Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Revista: J Biol Chem Ano de publicação: 1975 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Proteínas Quinases / AMP Cíclico / Eritrócitos Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Revista: J Biol Chem Ano de publicação: 1975 Tipo de documento: Article